RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.
Public ClinicalTrials.gov record NCT05180357. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Retrospective, Observational Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps Treated by FASENRA®
Study identification
- NCT ID
- NCT05180357
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 273 participants
Conditions and interventions
Conditions
Interventions
- FASENRA(benralizumab) Other
Other
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 22, 2021
- Primary completion
- Oct 27, 2022
- Completion
- Oct 27, 2022
- Last update posted
- Apr 18, 2023
2021 – 2022
United States locations
- U.S. sites
- 8
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Centennial | Colorado | 80112 | — |
| Research Site | Denver | Colorado | 80206 | — |
| Research Site | Glendale | New York | 11385 | — |
| Research Site | New York | New York | 10029 | — |
| Research Site | Rochester | New York | 14642 | — |
| Research Site | The Bronx | New York | 10461 | — |
| Research Site | Philadelphia | Pennsylvania | 19107 | — |
| Research Site | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05180357, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2023 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05180357 live on ClinicalTrials.gov.